786 related articles for article (PubMed ID: 9840942)
61. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.
Zhou JX; Niehans GA; Shar A; Rubins JB; Frizelle SP; Kratzke RA
Lung Cancer; 2001 Apr; 32(1):27-38. PubMed ID: 11282426
[TBL] [Abstract][Full Text] [Related]
62. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.
Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Söderkvist P
Oncogene; 1998 Feb; 16(6):803-8. PubMed ID: 9488045
[TBL] [Abstract][Full Text] [Related]
63. Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines.
McDoniels-Silvers AL; Herzog CR; Tyson FL; Malkinson AM; You M
Exp Lung Res; 2001; 27(3):297-318. PubMed ID: 11293330
[TBL] [Abstract][Full Text] [Related]
64. The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.
Gazzeri S; Della Valle V; Chaussade L; Brambilla C; Larsen CJ; Brambilla E
Cancer Res; 1998 Sep; 58(17):3926-31. PubMed ID: 9731504
[TBL] [Abstract][Full Text] [Related]
65. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
[TBL] [Abstract][Full Text] [Related]
66. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
Larsen CJ
Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
[TBL] [Abstract][Full Text] [Related]
67. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.
Quelle DE; Cheng M; Ashmun RA; Sherr CJ
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):669-73. PubMed ID: 9012842
[TBL] [Abstract][Full Text] [Related]
68. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
Marchetti A; Buttitta F; Pellegrini S; Bertacca G; Chella A; Carnicelli V; Tognoni V; Filardo A; Angeletti CA; Bevilacqua G
J Pathol; 1997 Feb; 181(2):178-82. PubMed ID: 9120722
[TBL] [Abstract][Full Text] [Related]
69. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
70. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
71. p53 expression in non small cell lung cancer: clinical and biological correlations.
Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F
Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413
[TBL] [Abstract][Full Text] [Related]
72. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
Vonlanthen S; Heighway J; Kappeler A; Altermatt HJ; Borner MM; Betticher DC
Int J Oncol; 2000 May; 16(5):951-7. PubMed ID: 10762631
[TBL] [Abstract][Full Text] [Related]
73. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
[TBL] [Abstract][Full Text] [Related]
74. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.
Meye A; Würl P; Hinze R; Berger D; Bache M; Schmidt H; Rath FW; Taubert H
J Pathol; 1998 Jan; 184(1):14-7. PubMed ID: 9582521
[TBL] [Abstract][Full Text] [Related]
75. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
Gorgoulis VG; Zacharatos P; Kotsinas A; Liloglou T; Kyroudi A; Veslemes M; Rassidakis A; Halazonetis TD; Field JK; Kittas C
Am J Pathol; 1998 Dec; 153(6):1749-65. PubMed ID: 9846966
[TBL] [Abstract][Full Text] [Related]
76. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
77. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.
Liggett WH; Sewell DA; Rocco J; Ahrendt SA; Koch W; Sidransky D
Cancer Res; 1996 Sep; 56(18):4119-23. PubMed ID: 8797577
[TBL] [Abstract][Full Text] [Related]
78. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
[TBL] [Abstract][Full Text] [Related]
79. Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.
Chen YJ; Shih LS; Chen YM
Int J Oncol; 1998 Aug; 13(2):249-54. PubMed ID: 9664118
[TBL] [Abstract][Full Text] [Related]
80. Methylation of AKAP12{alpha} promoter in lung cancer.
Jo UH; Whang YM; Sung JS; Kim YH
Anticancer Res; 2010 Nov; 30(11):4595-600. PubMed ID: 21115911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
